cbinet.com rank 361 |
Number of domains linking to cbinet.com 3 | semantic flow 0.29 |
Number of links to cbinet.com 4 | semantic flow 0.29 |
Number of domains linked from cbinet.com 3 | semantic flow 0.22 |
Number of links from cbinet.com 4 | semantic flow 0.22 |
Pages with highest topical PageRank pointing to domain.
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Pharma Forum 2018 | CBI http://www.cbinet.com/pharmaforum | 0.28 | 0.96 | 53 | 20 | 4 | 4 | 0 | 0 | |
Optimization of Cell & Gene Therapy Production - 03/26/2018 | CBI http://www.cbinet.com/conference/pc18455 | 0.21 | 1 | 49 | 15 | 0 | 0 | 1 | 1 | |
Finance and Accounting for Bioscience Companies - 09/25/2017 | CBI http://www.cbinet.com/compendia/conference/pc18270 | 0.18 | 1 | 36 | 15 | 0 | 0 | 0 | 0 |
On-topic pages from domain with highest topical PageRank having a few outgoing links and domains.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Pharma Forum 2018 | CBI http://www.cbinet.com/pharmaforum | 0.28 | 0.96 | 53 | 20 | 4 | 4 | 0 | 0 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://bioinfo.com/ | 2 | 0.17 | bioinfo.com |
http://pctcelltherapy.com/ | 1 | 0.07 | pctcelltherapy.com |
http://pharmaceuticalcommerce.com/ | 1 | 0.05 | pharmaceuticalcommerce.com |
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://silkroad.com/ | 2 | 0.12 | silkroad.com |
http://industrymatter.com/ | 1 | 0.05 | industrymatter.com |
http://ivtnetwork.com/ | 1 | 0.04 | ivtnetwork.com |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.cbinet.com/clinical | 1 | 0.16 | 0.95 | 0.09 | 0.83 | yes | 78 | 30 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/healthcare | 1 | 0.16 | 0.95 | 0.09 | 0.83 | yes | 59 | 22 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/compliance | 1 | 0.16 | 0.95 | 0.09 | 0.78 | yes | 77 | 26 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/company-profile | 1 | 0.16 | 0.96 | 0.09 | 1 | yes | 41 | 19 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/medical-affairs | 1 | 0.16 | 0.96 | 0.09 | 0.86 | yes | 77 | 27 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/validation | 1 | 0.16 | 0.96 | 0.09 | 0.74 | yes | 80 | 23 | 5 | 5 | 0 | 0 | |
http://www.cbinet.com/brand-strategy | 1 | 0.16 | 0.87 | 0.08 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.cbinet.com/conference/pc18455 | 1 | 0.21 | 0.97 | 0.07 | 1 | yes | 49 | 15 | 0 | 0 | 1 | 1 | |
http://www.cbinet.com/channel-strategy | 1 | 0.16 | 0.72 | 0.07 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.cbinet.com/conference/who-should-attend/pc18455 | 1 | 0.16 | 0.48 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://www.cbinet.com/conference/pc18455 | 14 | 0.21 | 0.97 | 1.21 | 1 | yes | 49 | 15 | 0 | 0 | 1 | 1 | |
http://www.cbinet.com/medical-affairs | 11 | 0.16 | 0.96 | 0.58 | 0.86 | yes | 77 | 27 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/financial-operations | 7 | 0.16 | 0.96 | 0.36 | 0.84 | yes | 77 | 28 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/clinical | 6 | 0.16 | 0.95 | 0.3 | 0.83 | yes | 78 | 30 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/compliance | 4 | 0.16 | 0.95 | 0.18 | 0.78 | yes | 77 | 26 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/validation | 4 | 0.16 | 0.96 | 0.16 | 0.74 | yes | 80 | 23 | 5 | 5 | 0 | 0 | |
http://www.cbinet.com/patient-access | 3 | 0.16 | 0.96 | 0.04 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
http://www.cbinet.com/careers | 2 | 0.16 | 0.95 | 0.12 | 0.91 | yes | 43 | 21 | 6 | 5 | 0 | 0 | |
http://www.cbinet.com/healthcare | 2 | 0.16 | 0.95 | 0.1 | 0.83 | yes | 59 | 22 | 4 | 4 | 0 | 0 | |
http://www.cbinet.com/ | 1 | 0.16 | 0.94 | 0.07 | 0.97 | yes | 47 | 22 | 4 | 4 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.